Home Turn Therapeutics™ Inc.

Turn Therapeutics™ Inc.

    Turn Therapeutics™ Closes Series B Round

    The capital raised will fund a large-scale, pre-launch, phase 4 trial for AtopX™ Eczema Emulsion, with enrollment scheduled to begin in Q1, 2020.

    RECENT COMMENTS